The combination of COX-2 inhibitors with chemotherapy was also assayed in a study in which the sensitivity of a human gastric cancer cell line MKN45 to cisplatin (alkylating agent) resulted increased by COX-2 downregulation with siRNA [35], suggesting a possible therapeutic application of this combination. The gene discussed is PTGS2; the disease is gastric cancer.